Boya Bio-Pharmaceutical Group: Secretary of the board of directors Fan Yiqin resigns but remains a director

NBD AI Bulletin-Boya Bio-Pharmaceutical Group Co., Ltd. (the Company, SZ 300294, closing price: 37.49 yuan) announced on the evening of June 30 that Ms. Fan Yiqin had offered to resign as secretary of the board of directors for personal reasons, but would remain as a director of the Company. As of the date of disclosure of this announcement, Ms. Fan yison holds about 1.05 million shares of the Company, and her spouse or other related persons do not hold shares in the Company, nor are there any commitments that should have been fulfilled.

NBD AI Review: The last time Boya Bio-Pharmaceutical Group Co., Ltd. issued a personnel change announcement was on May 18, 2020, the Company issued 2 personnel change announcements in the past year.

According to the Company's 2019 annual report, Boya Bio-pharmaceutical Group Co., Ltd. mainly engages in blood products, biochemical drugs, pharmaceutical distribution, pharmaceutical manufacturing and other business, accounting for 33.96%, 31.02%, 22.08%, 12.51% and 0.43% of its revenue respectively.

Boya Bio-Pharmaceutical Group Co., Ltd.'s chairman is Liao Xinxi, male, 52 years old, Chinese national, no permanent residence abroad, EMBA, Ph.D. student at Chinese Pharmaceutical University. The Company's general manager is Liang Xiaoming, male, 53 years old, Chinese national, no permanent residence abroad, undergraduate degree, EMBA, registered practicing pharmacist, senior engineer.

(By Cai Ding)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.